Meningitis causes inflammation of the meninges which is the protective membranes surrounding the in the brain and spinal cord. The inflammation is caused by an infection in the fluid surrounding the brain or spinal. Lymphocytic Choriomeningitis is a viral infectious disease that begins as the lymphocytic choriomeningitis virus. This virus is carried by the common house mouse and can be transferred to people through exposure to an infected mouse. It takes about 8-13 days for a person to become ill from the lymphocytic choriomeningitis virus. Lymphocytic Choriomeningitis is not a very serious form of meningitis and can be treated like aseptic meningitis.
Lymphocytic Choriomeningitis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Lymphocytic Choriomeningitis below!
For more information on how to use Laverne, please read the How to Guide.
We have 5133 products for the study of Lymphocytic Choriomeningitis that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Lymphocytic Choriomeningitis is also known as lymphocytic choriomeningitis, lymphocytic choriomeningitis virus encephalomyelitis (disorder), lymphocytic meningoencephalitis (disorder), lymphocytic meningitis (disorder), lcm.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.